CD19 and cancer: Although not previously shown to be directly related with cancers, several surface markers, such as CD19 and CD34, showed significant positive correlation (Pearson R > 0.5) with RUNX1T1 in RNA levels, whereas CD33 showed negative correlation (Pearson R = −0.36) (Figure S1).